Oncostatin-M Does Not Predict Treatment Response in Inflammatory Bowel Disease in a Pediatric Cohort.

Ezirike Ladipo, Jennifer; He, Zhaoping; Chikwava, Kudakwashe; Robbins, Katherine; Beri, Jonathan; Molle-Rios, Zarela

Ezirike Ladipo, Jennifer; He, Zhaoping; Chikwava, Kudakwashe; Robbins, Katherine; Beri, Jonathan; Molle-Rios, Zarela.

Affiliation

Ezirike Ladipo J; Division of Pediatric Gastroenterology.
He Z; Division of Pediatric Gastroenterology, Inova Children's Hospital.
Chikwava K; Division of Pediatric Gastroenterology, Pediatric Specialists of Virginia, Fairfax, VA.
Robbins K; Nemours Biomedical Research, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE.
Beri J; Division of Pathology.
Molle-Rios Z; Nemours Biomedical Research, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE.

J Pediatr Gastroenterol Nutr ; 73(3): 352-357, 2021 09 01.

Article in En | MEDLINE | ID: mdl-34117193

Subject(s)

Colitis; Inflammatory Bowel Diseases; Oncostatin M Receptor beta Subunit/genetics; Oncostatin M/genetics; Child; Humans; Inflammatory Bowel Diseases/drug therapy; Retrospective Studies; Tumor Necrosis Factor Inhibitors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Colitis / Oncostatin M / Oncostatin M Receptor beta Subunit Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Child / Humans Language: En Journal: J Pediatr Gastroenterol Nutr Year: 2021 Document type: Article

Fulltext

XML

PubMed Links

Search on Google